APA (7th ed.) Citation

Liu, Z., Li, X., Gao, Y., Liu, J., Feng, Y., Liu, Y., . . . Sun, Y. (2023). Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy. Molecular Cancer, 22(1), 1. https://doi.org/10.1186/s12943-023-01768-0

Chicago Style (17th ed.) Citation

Liu, Zongzhi, et al. "Epigenetic Reprogramming of Runx3 Reinforces CD8 + T-cell Function and Improves the Clinical Response to Immunotherapy." Molecular Cancer 22, no. 1 (2023): 1. https://doi.org/10.1186/s12943-023-01768-0.

MLA (9th ed.) Citation

Liu, Zongzhi, et al. "Epigenetic Reprogramming of Runx3 Reinforces CD8 + T-cell Function and Improves the Clinical Response to Immunotherapy." Molecular Cancer, vol. 22, no. 1, 2023, p. 1, https://doi.org/10.1186/s12943-023-01768-0.